Mercaptopurine Tablet
Product Images NDC 71921-150

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 71921-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mercaptopurine-container-1 (Mercaptopurine Container 1)

This is a warning label regarding a drug called Mercaptopurine, emphasizing the importance of using it under close medical supervision. It advises against taking larger doses or more frequently than prescribed to avoid potential harmful effects. The text also provides information about the manufacturer, storage conditions, and dosage recommendations.*

FDA Label Image

Mercaptopurine-container-2 (Mercaptopurine Container 2)

The text provides important information about a drug, including dosage instructions and storage guidelines. The drug should only be taken under close medical supervision and in the specified doses. Regular monitoring of blood counts is essential. The drug is manufactured in India by Pinnacle Life Science Pvt. Ltd. and is intended for Florida Pharmaceutical Products, LLC in Boca Raton, FL. The details can be encoded in a 2D Matrix code for human-readable format.*

FDA Label Image

Mercaptopurine-structure (Mercaptopurine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.